At the prestigious Health Food Expo, Ingredients and Contract Manufacture 2025 held in Tokyo International Forum, BONTAC drew global attention by showcasing its pioneering full-chain NAD⁺ supplement innovations. With over 12,000 industry professionals and 115 renowned exhibitors in attendance, the event spotlighted Bontac’s groundbreaking achievements.

Break through technological barriers and reshape industry standards
During the event, Dr. Qi Zhang, Founder and Chief Scientist of BONTAC, delivered a keynote titled "Next-Generation NAD⁺ Supplements: Reduced NMN and NRHM". She introduced two revolutionary products — BTCEH-NH® NMNH and Boncata® NRHM — both backed by proprietary global patents and offering superior bioavailability, molecular stability, and metabolic support.
BTCEH-NH® NMNH provides enhanced NAD⁺ boosting capabilities compared to traditional NMN, with promising applications in anti-aging, antioxidation, and metabolic regulation.
Boncata® NRHM combines nicotinamide riboside and malic acid through innovative crystal engineering, offering improved stability and absorption, opening new paths in energy metabolism, vascular health, and neuroprotection.
New category upgrade, redefining industry standards
At this exhibition, BONTAC showcased a range of core ingredients, including NMN, reduced NMN (NMNH), NAD, and NRHM, highlighting the company's in-depth research achievements and mature industrial layout across key nodes of the NAD⁺ metabolic pathway.
In particular, BONTAC has made significant strides in the NMN field, holding 24 invention patents globally — the most among national high-tech enterprises specializing in NMN technologies. Recognized as the sole raw material supplier for multiple international clinical studies, BONTAC's technological strength has earned widespread authoritative acknowledgment. The newly launched NMNH and NRHM products have each secured the world's first polymorphic invention patent. Their innovative structures enhance stability, fluidity, and absorption efficiency, setting new benchmarks for the nutritional supplement industry.
The exhibition attracted overwhelming attention, with numerous representatives from functional food and nutritional supplement brands across Japan and East Asia engaging in discussions and expressing strong interest in collaboration, laying a solid foundation for BONTAC's continued expansion into overseas markets.

Co-creating the Future: A Global Health Ecosystem
Looking ahead, BONTAC remains committed to advancing NAD⁺ metabolic research, innovating coenzyme pathways, and delivering high-efficiency, safe, and reliable raw material solutions — building a sustainable health ecosystem worldwide.
Learn more about BONTAC’s innovations at:https://www.bontac.com/